Geneva Advisors, LLC - BELLEROPHON THERAPEUTICS INC ownership

BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 18 filers reported holding BELLEROPHON THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Geneva Advisors, LLC ownership history of BELLEROPHON THERAPEUTICS INC
ValueSharesWeighting
Q2 2017$17,000
-10.5%
12,5000.0%0.00%
Q1 2017$19,000
+171.4%
12,5000.0%0.00%
Q4 2016$7,000
-61.1%
12,5000.0%0.00%
Q3 2016$18,000
-18.2%
12,5000.0%0.00%
Q2 2016$22,000
-29.0%
12,5000.0%0.00%
-100.0%
Q1 2016$31,00012,5000.00%
Other shareholders
BELLEROPHON THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Puissance Capital Management LP 8,298,755$17,261,00014.88%
NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. 15,138,486$31,488,0002.58%
VHCP Management II, LLC 4,149,378$8,631,0002.08%
Boxer Capital, LLC 1,857,143$3,863,0000.41%
Telemetry Investments, L.L.C. 199,000$414,0000.16%
EAM Investors, LLC 232,290$483,0000.08%
DRW Securities, LLC 70,000$146,0000.01%
Renaissance Technologies 1,032,900$2,148,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 23,000$48,0000.00%
STATE STREET CORP 13,800$29,0000.00%
View complete list of BELLEROPHON THERAPEUTICS INC shareholders